These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4083839)

  • 1. [Calcium oxalate stones and hyperoxaluria secondary to treatment with pyridoxilate].
    Wolf C; Maistre-Charransol G; Barthélémy C; Thomas E; Thomas J; Arvis G; Steg A
    Ann Urol (Paris); 1985; 19(5):313-7. PubMed ID: 4083839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Iatrogenic oxalic lithiasis caused by pyridoxilate].
    Wolf C; Maistre-Charransol G; Barthelemy C; Ottavioli JN; Thomas E; Thomas J
    Nephrologie; 1985; 6(5):225-7. PubMed ID: 4094636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1986 Dec; 116(50):1783-6. PubMed ID: 3798070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute renal failure caused by acute oxalosis after massive ingestion of pyridoxilate].
    Dequiedt P; Gosselin B; Benoit O; Le Maguer D; Lebleu J; MacNamara E; Pagniez D; Dracon M; Lelièvre G; Tacquet A
    Nephrologie; 1985; 6(5):228-30. PubMed ID: 4094637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of urinary calcium, oxalate and uric acid in calcium oxalate lithiasis].
    Dumoulin G; Haton D; Wolf JP; Henriet MT; Nguyen NU; Mougin C; Saint-Hillier Y; Combes M; Berthelay S
    Nephrologie; 1984; 5(5):189-91. PubMed ID: 6531054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piridoxilate-associated nephrocalcinosis: a new form of chronic oxalate nephropathy.
    Vigeral P; Kenouch S; Chauveau D; Mougenot B; Méry JP
    Nephrol Dial Transplant; 1987; 2(4):275-8. PubMed ID: 3118272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperoxaluria and renal calculi].
    Buño Soto A; Torres Jiménez R; García Puig J; Mateos Antón F
    Arch Esp Urol; 1996 Sep; 49(7):707-26. PubMed ID: 9020008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-induced oxalic lithiasis from pyridoxilate].
    Wolf C; Maistre-Charransol G; Barthelemy C; Thomas E; Thomas J
    Presse Med; 1984 Dec; 13(44):2703. PubMed ID: 6240037
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental and clinical studies on calcium urolithiasis: (I) Animal model for calcium oxalate urolithiasis using ethylene glycol and 1-alpha (OH) D3].
    Okada Y; Kawamura J; Nonomura M; Kuo YJ; Yoshida O
    Hinyokika Kiyo; 1985 Apr; 31(4):565-77. PubMed ID: 4036734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies of dietary influence on urinary oxalate in calcium oxalate stone formers].
    Arima K
    Hinyokika Kiyo; 1983 Dec; 29(12):1587-603. PubMed ID: 6687143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monohydrate and dihydrate oxalic lithiasis. Calculi, their macroscopic structure (radiographic and therapeutic impact). Calciuria and oxaluria].
    Thomas J; Charransol-Maistre G; Barthelemy C; Thomas E; Taboury JA; Taillandier E; Desgrez P; Legrand JC; Arvis G; Steg A
    Nephrologie; 1984; 5(4):181-3. PubMed ID: 6527721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piridoxilate-induced calcium oxalate calculi: a new drug-induced metabolic nephrolithiasis.
    Daudon M; Reveillaud RJ; Normand M; Petit C; Jungers P
    J Urol; 1987 Aug; 138(2):258-61. PubMed ID: 3599232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
    Penniston KL; Nakada SY
    Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Counteraction of oxalate induced nitrosative stress by supplementation of l-arginine, a potent antilithic agent.
    Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Varalakshmi P
    Clin Chim Acta; 2005 Apr; 354(1-2):159-66. PubMed ID: 15748613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [13 cases of drug-induced calculi].
    Teillac P; Daudon M; de Dreuzy O; Nguyen HV; Reveillaud RJ; Le Duc A
    Ann Urol (Paris); 1988; 22(4):278-81. PubMed ID: 2903714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [24-hour urinary oxalate excretion in healthy children and in children with calcium urolithiasis].
    Sikora P; Bieniaś B; Wawrzyszuk M; Zajaczkowska M
    Pol Merkur Lekarski; 2008; 24 Suppl 4():76-9. PubMed ID: 18924510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pyridoxine supplementation on recurrent stone formers.
    Murthy MS; Farooqui S; Talwar HS; Thind SK; Nath R; Rajendran L; Bapna BC
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):434-7. PubMed ID: 7141762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
    Sidhu H; Schmidt ME; Cornelius JG; Thamilselvan S; Khan SR; Hesse A; Peck AB
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.